Medicare currently covers TMS treatment for major depressive disorder only. If a PTSD patient also suffers from qualifying depression, treatment may still be covered.
Value Options covers TMS treatment when it is used to treat major depressive disorder. PTSD is not yet approved as a standalone diagnosis for coverage, but co-occurring depression may qualify.
Although TMS is approved for depression, Magellan covers it only under a depression diagnosis. PTSD patients may still qualify for coverage if they meet the criteria for major depressive disorder.
Although the FDA has approved TMS for depression, Aetna limits coverage to cases of treatment-resistant depression. If a PTSD patient also has major depression, they may still be eligible for TMS.
